Insulet 第二季財報承壓，衝擊 Tandem 及 DexCom (PODD:NASDAQ)
· seekingalpha.com
Insulet (PODD) 股價下跌，主因為該公司調降 2026 年營收指引；其他糖尿病相關個股 Tandem Diabetes (TNDM) 及 Dexcom (DXCM) 亦隨之下跌。請參閱更多報導。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...